Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;16(3):167-73.
doi: 10.1016/j.prrv.2014.07.006. Epub 2014 Aug 1.

New insights into the treatment of severe asthma in children

Lisa Giovannini-Chami  1 , Marc Albertini  2 , Pierre Scheinmann  3 , Jacques de Blic  3
Affiliations
Review

New insights into the treatment of severe asthma in children

Lisa Giovannini-Chami et al. Paediatr Respir Rev. 2015 Jun.

Abstract

Severe asthma accounts for 0.5% of the general paediatric population and 4.5% of children with asthma, representing the major burden of asthma-health-care-associated costs. After ensuring a diagnosis of asthma and excluding difficult-to-treat patients with co-morbidities and non-adherence profiles, there remains children with real therapy-resistant asthma for whom the recommendations are to treat beyond guidelines. We describe new insights into the treatment of severe asthma in children, regarding both "classic drugs" (corticosteroids, bronchodilators) and innovative biological therapies targeting airway inflammation and impaired innate immunity. All of these new avenues remain to be studied and validated in children and will require fine clinical and biological phenotyping.

Keywords: Anti-cytokine; Antiviral drugs; Bronchodilators; Inhaled corticosteroids; Innovative therapies; Omalizumab.

PubMed Disclaimer